 |
Fibronectin Peptide |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of burn injury progression of acute, deep dermal burns in hospitalized patients |
| USA Market Approval | USA |
| USA Designation Date | 2011-06-29 00:00:00 |
| Sponsor | NeoMatrix Therapeutics, Inc.;Long Island High Tech Incubator, 25 Health Sciences Drive;Stony Brook, New York, 11790 |
